Colon Cancer Research - Causes, Treatment, Symptoms

Colon Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Colon Cancer, including details on causes, treatment, symptoms.


Colon Cancer Research Today

Home

View Latest Issue

Information About Colon Cancer

Books on Colon Cancer

Advertising in Research Today

View Other Research Today Publications



Volume 2 (2005), Issue 3 (March)

  1. Risk of proximal colon neoplasia with distal hyperplastic polyps: a meta-analysis.
    Arch Intern Med, 165(4): 382-90. [Abstract] [Full-text]
  2. Hypersensitivity in DNA mismatch repair-deficient colon carcinoma cells to DNA polymerase reaction inhibitors.
    Cancer Lett, 220(1): 85-93. [Abstract] [Full-text]
  3. Differential staining of dysplastic aberrant crypt foci in the colon facilitates prediction of carcinogenic potentials of chemicals in rats.
    Cancer Lett, 220(1): 67-74. [Abstract] [Full-text]
  4. Effect of polyphenolic extracts from red wine and 4-OH-coumaric acid on 1,2-dimethylhydrazine-induced colon carcinogenesis in rats.
    Eur J Nutr, 44(2): 79-84. [Abstract] [Full-text]
  5. Endometrioid adenocarcinoma arising from endometriosis of the mesenterium of the sigmoid colon.
    Jpn J Clin Oncol, 35(3): 154-7. [Abstract] [Full-text]
  6. Quercetin decreases the expression of ErbB2 and ErbB3 proteins in HT-29 human colon cancer cells.
    J Nutr Biochem, 16(3): 155-62. [Abstract] [Full-text]
  7. Inhibitory effects of feeding with carrots or (-)-falcarinol on development of azoxymethane-induced preneoplastic lesions in the rat colon.
    J Agric Food Chem, 53(5): 1823-7. [Abstract] [Full-text]
  8. Colonic lipoma with florid vascular proliferation and nodule-aggregating appearance related to repeated intussusception.
    Pathol Int, 55(3): 160-4. [Abstract] [Full-text]
  9. Icodextrin reduces postoperative adhesion formation in rats without affecting peritoneal metastasis.
    Surgery, 137(3): 348-54. [Abstract] [Full-text]
  10. Alteration of gene expression in macroscopically normal colonic mucosa from individuals with a family history of sporadic colon cancer.
    Clin Cancer Res, 11(4): 1400-7. [Abstract] [Full-text]
  11. Duodenal cancer arising from the remaining duodenum after pylorus-preserving pancreatoduodenectomy for ampullary cancer in familial adenomatous polyposis.
    J Gastrointest Surg, 9(3): 389-92. [Abstract] [Full-text]
  12. Thymidylate synthase gene polymorphism as a prognostic factor for colon cancer.
    J Gastrointest Surg, 9(3): 336-42. [Abstract] [Full-text]
  13. From colonic polyps to colon cancer: pathophysiology, clinical presentation, and diagnosis.
    Clin Lab Med, 25(1): 135-77. [Abstract] [Full-text]
  14. Prevalence and predictors of multiple behavioral risk factors for colon cancer.
    Prev Med, 40(5): 527-34. [Abstract] [Full-text]
  15. IL-8 promotes cell proliferation and migration through metalloproteinase-cleavage proHB-EGF in human colon carcinoma cells.
    Cytokine, 29(6): 275-82. [Abstract] [Full-text]
  16. Monoclonal anti-idiotype antibody 6G6.C4 fused to GM-CSF is capable of breaking tolerance to carcinoembryonic antigen (CEA) in CEA-transgenic mice.
    Cancer Res, 65(5): 1925-33. [Abstract] [Full-text]
  17. Activation of p53 by MDM2 antagonists can protect proliferating cells from mitotic inhibitors.
    Cancer Res, 65(5): 1918-24. [Abstract] [Full-text]
  18. Iterative microarray and RNA interference-based interrogation of the SRC-induced invasive phenotype.
    Cancer Res, 65(5): 1814-21. [Abstract] [Full-text]
  19. Australian experience of a modified schedule of FOLFOX with high activity and tolerability and improved convenience in untreated metastatic colorectal cancer patients.
    Br J Cancer, 92(5): 832-7. [Abstract] [Full-text]
  20. Antisense inhibition of methylenetetrahydrofolate reductase reduces cancer cell survival in vitro and tumor growth in vivo.
    Clin Cancer Res, 11(5): 2047-52. [Abstract] [Full-text]
  21. Immunotherapy with autologous tumor cell-BCG vaccine in patients with colon cancer: a prospective study of medical and economic benefits.
    Vaccine, 23(17): 2379-87. [Abstract] [Full-text]
  22. Colonic neuroendocrine carcinoma in a child.
    Pediatr Radiol, 35(3): 339-43. [Abstract] [Full-text]
  23. Peroxisome proliferator-activated receptor expression and activation in normal human colonic epithelial cells and tubular adenomas.
    Scand J Gastroenterol, 40(2): 198-205. [Abstract] [Full-text]
  24. Ocular manifestations of familial adenomatous polyposis (Gardner syndrome).
    Ophthalmol Clin North Am, 18(1): 163-6, x. [Abstract] [Full-text]
  25. Neuromedin B and its receptor are mitogens in both normal and malignant epithelial cells lining the colon.
    Am J Physiol Gastrointest Liver Physiol, 288(4): G718-28. [Abstract] [Full-text]
  26. Bcl-XL small interfering RNA suppresses the proliferation of 5-fluorouracil-resistant human colon cancer cells.
    Mol Cancer Ther, 4(3): 451-6. [Abstract] [Full-text]
  27. Epidermal growth factor receptor (EGFR)-related protein inhibits multiple members of the EGFR family in colon and breast cancer cells.
    Mol Cancer Ther, 4(3): 435-42. [Abstract] [Full-text]
  28. Expression level of thymidylate synthase is a good predictor of chemosensitivity to 5-fluorouracil in colorectal cancer.
    J Gastroenterol, 40(2): 143-7. [Abstract] [Full-text]
  29. Suppression of tumor growth by oncolytic adenovirus-mediated delivery of an antiangiogenic gene, soluble Flt-1.
    Mol Ther, 11(4): 553-62. [Abstract] [Full-text]
  30. Founder mutation in familial adenomatous polyposis (FAP) in the Balearic Islands.
    Cancer Genet Cytogenet, 158(1): 70-4. [Abstract] [Full-text]
  31. Inducible nitric oxide synthase-dependent DNA damage in mouse model of inflammatory bowel disease.
    Cancer Sci, 96(3): 157-63. [Abstract] [Full-text]
  32. Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer.
    J Clin Oncol, 23(9): 1819-25. [Abstract] [Full-text]
  33. Expression of stress response protein glucose regulated protein-78 mediated by c-Myb.
    Int J Biochem Cell Biol, 37(6): 1254-68. [Abstract] [Full-text]
  34. Hepatoid malignancy of unknown origin--a diagnostic conundrum: review of literature and case report of collision with adenocarcinoma.
    Surg Oncol, 14(1): 11-25. [Abstract] [Full-text]
  35. Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study.
    Mod Pathol, 18(4): 511-8. [Abstract] [Full-text]
  36. Expression of the carcinoembryonic antigen gene is inhibited by SOX9 in human colon carcinoma cells.
    Cancer Res, 65(6): 2193-8. [Abstract] [Full-text]
  37. A proteomics approach to identify changes in protein profiles in pre-cancerous colon.
    Biochem Biophys Res Commun, 330(1): 81-7. [Abstract] [Full-text]
  38. DNA damage and aberrant crypt foci as putative biomarkers to evaluate the chemopreventive effect of annatto (Bixa orellana L.) in rat colon carcinogenesis.
    Mutat Res, 582(1): 146-54. [Abstract] [Full-text]
  39. Hematopoietic cells regulate the angiogenic switch during tumorigenesis.
    Blood, 105(7): 2757-63. [Abstract] [Full-text]
  40. MET signalling in primary colon epithelial cells leads to increased transformation irrespective of aberrant Wnt signalling.
    Br J Cancer, 92(6): 1078-83. [Abstract] [Full-text]
  41. SNAIL vs vitamin D receptor expression in colon cancer: therapeutics implications.
    Br J Cancer, 92(6): 985-9. [Abstract] [Full-text]
  42. Colonic tumorigenesis in BubR1+/-ApcMin/+ compound mutant mice is linked to premature separation of sister chromatids and enhanced genomic instability.
    Proc Natl Acad Sci U S A, 102(12): 4365-70. [Abstract] [Full-text]
  43. Core 3 synthase is down-regulated in colon carcinoma and profoundly suppresses the metastatic potential of carcinoma cells.
    Proc Natl Acad Sci U S A, 102(12): 4572-7. [Abstract] [Full-text]
  44. Human colon cancer cells lacking Bax resist curcumin-induced apoptosis and Bax requirement is dispensable with ectopic expression of Smac or downregulation of Bcl-XL.
    Carcinogenesis, 26(4): 713-23. [Abstract] [Full-text]
  45. Osteopontin silencing by small interfering RNA suppresses in vitro and in vivo CT26 murine colon adenocarcinoma metastasis.
    Carcinogenesis, 26(4): 741-51. [Abstract] [Full-text]
  46. Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smoke.
    Carcinogenesis, 26(4): 827-34. [Abstract] [Full-text]
  47. Induction of colon tumors in C57BL/6J mice fed MeIQx, IQ, or PhIP followed by dextran sulfate sodium treatment.
    Toxicol Sci, 84(2): 243-8. [Abstract] [Full-text]
  48. Induction of an antigen cascade by diversified subcutaneous/intratumoral vaccination is associated with antitumor responses.
    Clin Cancer Res, 11(6): 2416-26. [Abstract] [Full-text]
  49. Cytoplasmic phospholipase A2 levels correlate with apoptosis in human colon tumorigenesis.
    Clin Cancer Res, 11(6): 2265-71. [Abstract] [Full-text]
  50. Caveolin-1 mediates the expression and localization of cathepsin B, pro-urokinase plasminogen activator and their cell-surface receptors in human colorectal carcinoma cells.
    J Cell Sci, 118: 1493-503. [Abstract] [Full-text]
  51. Expression of the nm23 homologues nm23-H4, nm23-H6, and nm23-H7 in human gastric and colon cancer.
    J Pathol, 205(5): 623-32. [Abstract] [Full-text]
  52. A kindred with MYH-associated polyposis and pilomatricomas.
    Am J Med Genet A, 134(2): 212-4. [Abstract] [Full-text]
  53. The retroperitoneal surface in distal caecal and proximal ascending colon carcinoma: the Cinderella surgical margin?
    J Clin Pathol, 58(4): 426-8. [Abstract] [Full-text]
  54. Cancer biology and necrotic changes in metastatic lymph nodes and survival of colon cancer patients.
    Am J Surg, 189(3): 364-8. [Abstract] [Full-text]
  55. Killing tumor cells: the effect of photodynamic therapy using mono-L-aspartyl chlorine and NS-398.
    Am J Surg, 189(3): 302-5. [Abstract] [Full-text]
  56. Energy balance, insulin-related genes and risk of colon and rectal cancer.
    Int J Cancer, 115(1): 148-54. [Abstract] [Full-text]
  57. Necrotic and apoptotic features of cell death in response to Foscan photosensitization of HT29 monolayer and multicell spheroids.
    Biochem Pharmacol, 69(8): 1167-76. [Abstract] [Full-text]
  58. Overexpression of a novel superoxide-producing enzyme, NADPH oxidase 1, in adenoma and well differentiated adenocarcinoma of the human colon.
    Cancer Lett, 221(1): 97-104. [Abstract] [Full-text]
  59. Low microsatellite instability is associated with poor prognosis in stage C colon cancer.
    J Clin Oncol, 23(10): 2318-24. [Abstract] [Full-text]
  60. Comparison of the effects of the chemopreventive agent resveratrol and its synthetic analog trans 3,4,5,4'-tetramethoxystilbene (DMU-212) on adenoma development in the Apc(Min+) mouse and cyclooxygenase-2 in human-derived colon cancer cells.
    Int J Cancer, 115(2): 194-201. [Abstract] [Full-text]
  61. CD44 promotes resistance to apoptosis in murine colonic epithelium.
    J Cell Physiol, 203(3): 583-8. [Abstract] [Full-text]
Place a permanent text-link or advertisement here for just US$15.

© 2004-2008 Colon Cancer Research Today. All Rights Reserved.



Colon Cancer Research Today Archive:

Volume 1 (2004)
  Issue 1 (November)
  Issue 2 (December)

Volume 2 (2005)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 3 (2006)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 4 (2007)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 5 (2008)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)



Colon Cancer Books

Colon Cancer 2007: Johns Hopkins White Papers

Colon Cancer 2007: Johns Hopkins White Papers